| ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease N Colombo, C Sessa, A Du Bois, J Ledermann, WG McCluggage, ... Annals of Oncology 30 (5), 672-705, 2019 | 1038 | 2019 |
| Neutrophils escort circulating tumour cells to enable cell cycle progression BM Szczerba, F Castro-Giner, M Vetter, I Krol, S Gkountela, J Landin, ... Nature 566 (7745), 553-557, 2019 | 939 | 2019 |
| Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding S Gkountela, F Castro-Giner, BM Szczerba, M Vetter, J Landin, R Scherrer, ... Cell 176 (1), 98-112. e14, 2019 | 703 | 2019 |
| Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer VA Heinzelmann-Schwarz, M Gardiner-Garden, SM Henshall, J Scurry, ... Clinical Cancer Research 10 (13), 4427-4436, 2004 | 273 | 2004 |
| Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines F Jacob, R Guertler, S Naim, S Nixdorf, A Fedier, NF Hacker, ... PloS one 8 (3), e59180, 2013 | 256 | 2013 |
| No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting F Jacob, M Meier, R Caduff, D Goldstein, T Pochechueva, N Hacker, ... Gynecologic oncology 121 (3), 487-491, 2011 | 247 | 2011 |
| Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ... The Journal of clinical investigation 128 (11), 4912-4923, 2018 | 227 | 2018 |
| Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy C Claus, C Ferrara, W Xu, J Sam, S Lang, F Uhlenbrock, R Albrecht, ... Science translational medicine 11 (496), eaav5989, 2019 | 204 | 2019 |
| Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5‐aminolevulinic acid MK Fehr, R Hornung, A Degen, VA Schwarz, D Fink, U Haller, P Wyss Lasers in Surgery and Medicine: The Official Journal of the American Society …, 2002 | 194 | 2002 |
| The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells A Fedier, RA Steiner, VA Schwarz, L Lenherr, U Haller, D Fink International journal of oncology 22 (5), 1169-1173, 2003 | 170 | 2003 |
| Resistance to topoisomerase poisons due to loss of DNA mismatch repair A Fedier, VA Schwarz, H Walt, RD Carpini, U Haller, D Fink International journal of cancer 93 (4), 571-576, 2001 | 168 | 2001 |
| Microtubule-depolymerizing agents used in antibody–drug conjugates induce antitumor immunity by stimulation of dendritic cells P Müller, K Martin, S Theurich, J Schreiner, S Savic, G Terszowski, ... Cancer immunology research 2 (8), 741-755, 2014 | 162 | 2014 |
| Protein significance analysis in selected reaction monitoring (SRM) measurements CY Chang, P Picotti, R Hüttenhain, V Heinzelmann-Schwarz, M Jovanovic, ... Molecular & Cellular Proteomics 11 (4), 2012 | 159 | 2012 |
| Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status M Anugraham, F Jacob, S Nixdorf, AV Everest-Dass, ... Molecular & Cellular Proteomics 13 (9), 2213-2232, 2014 | 152 | 2014 |
| Photodynamic therapy of locoregional breast cancer recurrences using a chlorin‐type photosensitizer P Wyss, V Schwarz, D Dobler‐Girdziunaite, R Hornung, H Walt, A Degen, ... International journal of cancer 93 (5), 720-724, 2001 | 141 | 2001 |
| The metastatic spread of breast cancer accelerates during sleep Z Diamantopoulou, F Castro-Giner, FD Schwab, C Foerster, M Saini, ... Nature 607 (7917), 156-162, 2022 | 137 | 2022 |
| A distinct molecular profile associated with mucinous epithelial ovarian cancer VA Heinzelmann-Schwarz, M Gardiner-Garden, SM Henshall, JP Scurry, ... British journal of cancer 94 (6), 904-913, 2006 | 137 | 2006 |
| Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid MK Fehr, R Hornung, VA Schwarz, R Simeon, U Haller, P Wyss Gynecologic oncology 80 (1), 62-66, 2001 | 134 | 2001 |
| LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin PA Cowin, J George, S Fereday, E Loehrer, P Van Loo, C Cullinane, ... Cancer research 72 (16), 4060-4073, 2012 | 111 | 2012 |
| The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells CE Ford, E Jary, SSQ Ma, S Nixdorf, VA Heinzelmann-Schwarz, RL Ward PloS one 8 (1), e54362, 2013 | 110 | 2013 |
Francis JacobUniversität BaselVerified email at unibas.ch
